Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.93 USD | +1.30% | +1.35% | -4.64% |
Financials (USD)
Sales 2024 * | 45.83B | Sales 2025 * | 46.36B | Capitalization | 97.89B |
---|---|---|---|---|---|
Net income 2024 * | -3.95B | Net income 2025 * | 10.31B | EV / Sales 2024 * | 2.98 x |
Net Debt 2024 * | 38.57B | Net Debt 2025 * | 30.42B | EV / Sales 2025 * | 2.77 x |
P/E ratio 2024 * |
-33.2
x | P/E ratio 2025 * |
8.78
x | Employees | 34,100 |
Yield 2024 * |
5.01% | Yield 2025 * |
5.23% | Free-Float | 69.13% |
Latest transcript on Bristol-Myers Squibb Company
1 day | +0.96% | ||
1 week | -1.67% | ||
Current month | -10.93% | ||
1 month | -6.38% | ||
3 months | -3.57% | ||
6 months | -15.04% | ||
Current year | -5.87% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 15-01-31 | |
David Elkins
DFI | Director of Finance/CFO | 55 | 19-11-19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 19-11-19 |
Peter Arduini
BRD | Director/Board Member | 59 | 16-03-31 |
Derica Rice
BRD | Director/Board Member | 59 | 20-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
12.97% | 215 M€ | +12.86% | - | |
4.99% | 2 M€ | -.--% | ||
4.01% | 18 M€ | +1.40% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 48.93 | +1.30% | 10 303 709 |
24-04-18 | 48.3 | +0.96% | 10,917,581 |
24-04-17 | 47.84 | -0.87% | 11,763,053 |
24-04-16 | 48.26 | -0.52% | 11,931,277 |
24-04-15 | 48.51 | +0.48% | 11,943,603 |
Delayed Quote Nyse, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.87% | 97.89B | |
+27.97% | 672B | |
+23.58% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.96% | 211B | |
-0.41% | 203B | |
-10.02% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- BMY Stock